Research in Pharmaceutical Sciences,
Journal Year:
2025,
Volume and Issue:
20(1), P. 1 - 24
Published: Jan. 1, 2025
Individuals
with
inflammatory
bowel
disease
(IBD)
are
at
a
higher
risk
of
developing
mental
disorders,
such
as
anxiety
and
depression.
The
imbalance
between
the
intestinal
microbiota
its
host,
known
dysbiosis,
is
one
factors,
disrupting
balance
metabolite
production
their
signaling
pathways,
leading
to
progression.
A
metabolomics
approach
can
help
identify
role
gut
in
disorders
associated
IBD
by
evaluating
metabolites
comprehensively.
This
narrative
review
focuses
on
studies
that
have
comprehensively
elucidated
altered
microbial
pathways
underlying
patients.
information
was
compiled
searching
PubMed,
Web
Science,
Scopus,
Google
Scholar
from
2005
2023.
findings
indicated
dysbiosis
patients
leads
depression
through
disturbances
metabolism
carbohydrates,
sphingolipids,
bile
acids,
neurotransmitters,
neuroprotective,
amino
acids.
Furthermore,
reduction
neuroprotective
factors
increase
inflammation
observed
these
also
contribute
worsening
psychological
symptoms.
Analyzing
profile
comparing
it
healthy
individuals
using
advanced
technologies
like
metabolomics,
aids
early
diagnosis
prevention
disorders.
allows
for
more
precise
identification
microbes
responsible
production,
enabling
development
tailored
dietary
pharmaceutical
interventions
or
targeted
manipulation
microbiota.
Gut Microbes,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: Feb. 25, 2024
Patients
with
inflammatory
bowel
disease
(IBD),
including
ulcerative
colitis
(UC),
show
an
increased
incidence
of
anxiety
and
depression;
however,
the
association
between
UC-associated
psychiatric
disorders
gut
microbiota
is
unclear.
This
study
aimed
to
examine
whether
from
patients
UC
can
alter
colonic
gene
expression,
leading
anxiety-
depression-like
behavior
in
mice
receiving
fecal
transplantation
(FMT).
RNA
sequencing
transcriptome
analyses
revealed
a
difference
expression
FMT
(UC-FMT
mice)
those
healthy
controls
(HC-FMT
mice).
Gene
ontology
analysis
downregulation
neuropeptide
signaling
pathways,
Y
(NPY)
colons
UC-FMT
mice.
The
protein
levels
NPY
also
decreased
colon
plasma
compared
HC-FMT
oral
administration
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(5), P. 1361 - 1361
Published: Feb. 27, 2024
Inflammatory
bowel
diseases
(IBDs)
have
seen
an
exponential
increase
in
incidence,
particularly
among
pediatric
patients.
Psychological
stress
is
a
significant
risk
factor
influencing
the
disease
course.
This
review
assesses
interaction
between
and
progression,
focusing
on
articles
that
quantified
inflammatory
markers
IBD
patients
exposed
to
varying
degrees
of
psychological
stress.
Research in Psychotherapy Psychopathology Process and Outcome,
Journal Year:
2024,
Volume and Issue:
26(3)
Published: Jan. 15, 2024
A
comprehensive
investigation
of
psychological
features
in
chronic
patients
is
very
important
for
tailoring
effective
treatments.
In
this
study
we
tested
anxiety,
depression,
health
related
quality
life
(HR-QoL),
alexithymia,
coping
styles,
and
defense
mechanisms,
eighty-four
with
Crohn
disease
(CD)
ulcerative
colitis
(UC).
Participants
reported
low
to
moderate
HRQoL
apart
from
alexithymia.
Women
experienced
lower
QoL
higher
levels
anxiety
depressive
symptoms.
Coping
strategies
were
distress
symptoms
QoL.
Positive
attitude
principalization,
showed
negative
associations
alexithymia
also
found
be
associated
mental
health.
CD
used
significantly
more
turning
against
objects
(p=0.02)
projections
(p=0.01)
UC
reversal
(p=0.04).
Elderly
women
perceived
Multiple
regression
analysis
revealed
depression
independently
Significant
differences
emerged
styles
among
UC.
participants
maladaptive
which
distress,
together
level
Findings
suggest
that
aspects
play
a
key
role
suffering
inflammatory
bowel
diseases.
multi-integrated
clinical
strategy
including
psychotherapeutic
interventions
should
considered
treating
Cells,
Journal Year:
2024,
Volume and Issue:
13(2), P. 177 - 177
Published: Jan. 17, 2024
Inflammatory
bowel
disease
(IBD),
a
common
term
for
Crohn’s
and
ulcerative
colitis,
is
chronic,
relapse-remitting
condition
of
the
gastrointestinal
tract
that
increasing
worldwide.
Psychiatric
comorbidities,
including
depression
anxiety,
are
more
prevalent
in
IBD
patients
than
healthy
individuals.
Evidence
suggests
varying
levels
neuroinflammation
might
underlie
these
states
patients.
Within
this
context,
microglia
crucial
non-neural
cells
brain
responsible
innate
immune
responses
following
inflammatory
insults.
Alterations
microglia’s
functions,
such
as
secretory
profile,
phagocytic
activity,
synaptic
pruning,
play
significant
roles
mediating
psychiatric
manifestations
IBD.
In
review,
we
discuss
role
played
by
IBD-associated
comorbidities.
Alimentary Pharmacology & Therapeutics,
Journal Year:
2024,
Volume and Issue:
60(8), P. 1062 - 1074
Published: Aug. 21, 2024
Elevated
allostatic
load
(AL)
has
been
associated
with
the
risk
and
poor
prognosis
of
many
chronic
diseases.
The
association
between
AL
inflammatory
bowel
disease
(IBD)
is
unknown.
Cancer Research,
Journal Year:
2024,
Volume and Issue:
84(5), P. 645 - 647
Published: March 4, 2024
Abstract
Psychologic
stress
significantly
impacts
colorectal
cancer,
and
chronic
is
known
to
decrease
treatment
efficacy
survival
rates
in
patients
with
cancer.
Previous
studies
have
linked
psychologic
changes
the
gut
microbiota,
role
of
microbiota
cancer
progression
well
characterized.
Despite
this,
mechanistic
link
between
remains
unclear.
In
this
issue
Cancer
Research,
Cao
colleagues
reveal
that
exacerbates
by
reducing
presence
Lactobacillus
johnsonii
(L.
johnsonii)
its
metabolite
protocatechuic
acid
(PCA).
The
authors
demonstrate
an
increase
β-catenin
expression
as
major
mechanism
which
potentiates
stemness
pathogenesis.
Administration
L.
or
PCA
stressed
mice
decreased
activity
progression.
This
study
defines
a
precise
underlying
progression,
emphasizing
relevance
well-being
outcome.
addition,
demonstrates
potential
supplementation
promising
therapeutics
for
treatment.
See
related
article
et
al.,
p.
771
Diseases,
Journal Year:
2024,
Volume and Issue:
12(8), P. 179 - 179
Published: Aug. 8, 2024
Helicobacter
pylori
infection
has
significant
epidemiological
relevance
due
to
the
carcinogenic
nature
of
this
bacterium,
which
is
potentially
associated
with
cancer.
When
detected,
it
should
ideally
be
eradicated
using
a
treatment
that
currently
involves
combination
gastric
acid
suppressors
and
multiple
antibiotics.
However,
raises
questions
regarding
efficacy
safety
profiles
in
patients
specific
comorbidities,
including
inflammatory
bowel
diseases
(IBD).
Eradication
therapy
for
H.
includes
components
adverse
gastrointestinal
events,
such
as
Clostridioides
difficile
colitis.
This
necessitates
quantifying
risk
through
dedicated
studies
determine
whether
antimicrobial
could
significantly
IBD
relapse
or
exacerbation
pre-existing
IBD,
well
lead
de
novo
onset
IBD.
Although
available
evidence
reassuring
about
eradication
limited,
there
are
no
recommendations
particular
situation
leading
international
guidelines.
Therefore,
need
evaluate
regimens
both
clinical
trial
settings
real-life
studies.
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(8), P. 1236 - 1236
Published: April 21, 2024
Inflammatory
bowel
disease
(IBD),
a
continuum
of
chronic
inflammatory
diseases,
is
tightly
associated
with
immune
system
dysregulation
and
dysbiosis,
leading
to
inflammation
in
the
gastrointestinal
tract
(GIT)
multiple
extraintestinal
manifestations.
The
pathogenesis
IBD
not
completely
elucidated.
However,
it
an
increased
risk
colorectal
cancer
(CRC),
which
one
most
common
malignancies.
In
both
CRC,
complex
interplay
occurs
between
gut
microbiota
(GM),
alteration
GM
composition.
Melatonin,
neuroendocrine
hormone,
was
found
be
involved
this
interplay,
especially
since
present
high
amounts
gut,
some
protective
effects.
Actually,
melatonin
enhances
integrity
intestinal
mucosal
barrier,
regulates
response,
alleviates
inflammation,
attenuates
oxidative
stress.
Thereby,
authors
summarize
multifactorial
interaction
focusing
on
new
findings
related
mechanisms
action
addition
its
documented
positive
outcomes
treatment
these
two
pathologies
possible
future
perspectives
use
as
adjuvant
therapy.